<DOC>
	<DOC>NCT01937663</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of tapered KWA-0711 dose in chronic constipation patients.</brief_summary>
	<brief_title>A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>The patients who experienced fewer than three spontaneous bowel movements per week for more than 6 months prior to the enrollment. The patients who experienced one or more of the following signs or symptoms during more than 25% of bowel movements for more than 6 months: straining, lumpy or hard stools, and a sensation of incomplete evacuation Patients who have secondary constipation caused by systemic disorder. Patients who have organic constipation. Patients who received intestinal resection.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Chronic Constipation</keyword>
	<keyword>Constipation</keyword>
	<keyword>Functional gastrointestinal disorders</keyword>
</DOC>